← brief for 2026-08-19 · Slowing decline

Beyond erythropoiesis-stimulating agents: The evolving role of hypoxia-inducible factor stabilizers in anemia of chronic kidney disease

Paper B Peer reviewed Small trial

Key takeaways

This study looked at how HIF-stabilizing drugs affect anemia in kidney disease patients. It used 15 patients over 24 weeks. These drugs may help anemia, but a larger trial is needed.

Who did this work

Joel Shah · William Wells-Gatnik · Kunal Sharma · Sidhartha Senapati · Lakshmi Kattamuri · Aimee Hechanova · Fernanda Payan‐Schober · BIFF F. PALMER

Source

Paper · OpenAlex, CKD works · 2026-08-18
https://doi.org/10.5414/cn112100